Unveiling the Anti-cancer Efficiency of Chebulagic Acid-Mediated Apoptotic Mechanisms in HepG2 Cell Line

Zheng, Shuo; Huang, Yihong

doi:10.3923/ijp.2021.229.242

International J. of Pharmacology

2021

DOI: 10.3923/ijp.2021.229.242

|View full text |Cite

Unveiling the Anti-cancer Efficiency of Chebulagic Acid-Mediated Apoptotic Mechanisms in HepG2 Cell Line

Shuo Zheng¹,

Yihong Huang²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Chebulinic Acid: An Incipient Anticancer Agent

Aashima,

Rathi,

Shilpi

et al. 2024

PRA

View full text Add to dashboard Cite

Background: Terminalia chebula (T. chebula) comprising chebulinic acid as its principle active constituent is used to cure various diseases. T. chebula and chebulinic acid are used as antimicrobial, antioxidant, antidiabetic, anti-inflammatory, hepatoprotective, antimutagenic, radioprotective, cardioprotective, antiproliferative, antiarthritic, anticaries, and so on. Objective: The objective of this current study is to give an overview of the recent literature and patents of T. chebula and chebulinic acid including methods of its isolation/extraction and their application in the prevention of various cancers and other diseases. Methods: Present research and patents highlighting the anti-cancer potential of T. chebula and chebulinic acid have been studied and discussed keeping in view the scientific novelty and impact. Results: Both T. chebula and chebulinic acid are currently being explored for their anticancer potential in vitro and in vivo. They are either incorporated alone or in combination with other plants or drugs to show their activity and many clinical trials are also going on various potentials of the plant and chebulinic acid. Novel extraction techniques are also explored and patented. Efforts are being made to improve the bioavailability by developing Novel herbal drug delivery systems of the plant extract or chebulinic acid itself. Conclusion: Anti-cancer potential of T. chebula and chebulinic acid may be well established by promising clinical trials and may open new interventions in various tumors. Clinical trials in conjunction with standard therapies are required to explore and validate the actual potential of T. chebula and chebulinic acid respectively.

show abstract

Chebulinic Acid: An Incipient Anticancer Agent

Aashima,

Rathi,

Shilpi

et al. 2024

PRA

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Unveiling the Anti-cancer Efficiency of Chebulagic Acid-Mediated Apoptotic Mechanisms in HepG2 Cell Line

Cited by 1 publication

References 32 publications

Chebulinic Acid: An Incipient Anticancer Agent

Chebulinic Acid: An Incipient Anticancer Agent

Contact Info

Product

Resources

About